187 related articles for article (PubMed ID: 31929853)
21. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
Kim NH; D'Armini AM; Grimminger F; Grünig E; Hoeper MM; Jansa P; Mayer E; Neurohr C; Simonneau G; Torbicki A; Wang C; Fritsch A; Davie N; Ghofrani HA
Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
[TBL] [Abstract][Full Text] [Related]
22. Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension.
Groth A; Saxer S; Bader PR; Lichtblau M; Furian M; Schneider SR; Schwarz EI; Bloch KE; Ulrich S
Int J Cardiol; 2018 Nov; 270():262-267. PubMed ID: 29891241
[TBL] [Abstract][Full Text] [Related]
23. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
Halank M; Hoeper MM; Ghofrani HA; Meyer FJ; Stähler G; Behr J; Ewert R; Fletcher M; Colorado P; Nikkho S; Grimminger F
Respir Med; 2017 Jul; 128():50-56. PubMed ID: 28610669
[TBL] [Abstract][Full Text] [Related]
24. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.
Godinas L; Sattler C; Lau EM; Jaïs X; Taniguchi Y; Jevnikar M; Weatherald J; Sitbon O; Savale L; Montani D; Simonneau G; Humbert M; Laveneziana P; Garcia G
J Heart Lung Transplant; 2017 Nov; 36(11):1234-1242. PubMed ID: 28666570
[TBL] [Abstract][Full Text] [Related]
25. Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies.
Fauché A; Presles E; Sanchez O; Jaïs X; Le Mao R; Robin P; Pernod G; Bertoletti L; Jego P; Parent F; Lemarié CA; Leven F; Le Roux PY; Salaun PY; Nonent M; Girard P; Lacut K; Savale L; Mélac S; Guégan M; Mismetti P; Laporte S; Leroyer C; Montani D; Couturaud F; Tromeur C;
J Thromb Haemost; 2022 Dec; 20(12):2850-2861. PubMed ID: 36017744
[TBL] [Abstract][Full Text] [Related]
26. Antioxidant Barrier, Redox Status, and Oxidative Damage to Biomolecules in Patients with Colorectal Cancer. Can Malondialdehyde and Catalase Be Markers of Colorectal Cancer Advancement?
Zińczuk J; Maciejczyk M; Zaręba K; Romaniuk W; Markowski A; Kędra B; Zalewska A; Pryczynicz A; Matowicka-Karna J; Guzińska-Ustymowicz K
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31652642
[TBL] [Abstract][Full Text] [Related]
27. CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Olsson KM; Olle S; Fuge J; Welte T; Hoeper MM; Lerch C; Maegel L; Haller H; Jonigk D; Schiffer L
Respir Res; 2016 Feb; 17():21. PubMed ID: 26927848
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study.
Li C; Zhao J; Liu S; Song W; Zhu J; Hua L; Wang Q; Li M; Zeng X; Zhao Y
Lupus; 2018 Dec; 27(14):2206-2214. PubMed ID: 30451640
[TBL] [Abstract][Full Text] [Related]
29. Long-term real world clinical outcomes of macitentan therapy in chronic thromboembolic pulmonary hypertension.
van Thor MCJ; Ten Klooster L; Snijder RJ; Mager JJ; Post MC
Respir Med; 2020 Jun; 167():105966. PubMed ID: 32421542
[TBL] [Abstract][Full Text] [Related]
30. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.
Naito A; Tanabe N; Jujo T; Shigeta A; Sugiura T; Sakao S; Ishida K; Tatsumi K
PLoS One; 2014; 9(11):e113086. PubMed ID: 25412085
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.
Delcroix M; Lang I; Pepke-Zaba J; Jansa P; D'Armini AM; Snijder R; Bresser P; Torbicki A; Mellemkjaer S; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Jaïs X; Ambroz D; Treacy C; Morsolini M; Jenkins D; Lindner J; Dartevelle P; Mayer E; Simonneau G
Circulation; 2016 Mar; 133(9):859-71. PubMed ID: 26826181
[TBL] [Abstract][Full Text] [Related]
32. Serum Bilirubin and 6-min Walk Distance as Prognostic Predictors for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Prospective Cohort Study.
Gong JN; Zhai ZG; Yang YH; Liu Y; Gu S; Kuang TG; Xie WM; Miao R; Wang C
Chin Med J (Engl); 2015 Dec; 128(23):3125-31. PubMed ID: 26612283
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
[TBL] [Abstract][Full Text] [Related]
34. An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study.
Togha M; Razeghi Jahromi S; Ghorbani Z; Ghaemi A; Rafiee P
BMC Neurol; 2019 Dec; 19(1):323. PubMed ID: 31837702
[TBL] [Abstract][Full Text] [Related]
35. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA
PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of chronic thromboembolic pulmonary hypertension in Korea: results from the Korean registry.
Park SY; Lee SM; Shin JW; Choi BW; Kim H; Lee JS; Lee SD; Park SS; Moon HS; Park YB
Korean J Intern Med; 2016 Mar; 31(2):305-12. PubMed ID: 26689916
[TBL] [Abstract][Full Text] [Related]
37. [Chronic thromboembolic pulmonary hypertension: Time delay from onset of symtoms to diagnosis and clinical condition at diagnosis].
Held M; Grün M; Holl R; Walter F; Schäfers HJ; Graeter T; Wilkens H; Jany B
Dtsch Med Wochenschr; 2014 Aug; 139(33):1647-52. PubMed ID: 25093951
[TBL] [Abstract][Full Text] [Related]
38. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
[TBL] [Abstract][Full Text] [Related]
39. Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.
Kopeć G; Waligóra M; Tyrka A; Jonas K; Pencina MJ; Zdrojewski T; Moertl D; Stokwiszewski J; Zagożdżon P; Podolec P
Sci Rep; 2017 Feb; 7():41650. PubMed ID: 28198422
[TBL] [Abstract][Full Text] [Related]
40. Standard PAH therapy improves long term survival in CTEPH patients.
Seyfarth HJ; Halank M; Wilkens H; Schäfers HJ; Ewert R; Riedel M; Schuster E; Pankau H; Hammerschmidt S; Wirtz H
Clin Res Cardiol; 2010 Sep; 99(9):553-6. PubMed ID: 20419456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
